Clinical Trial Update: Evaluation of Long-Acting Muscarinic Antagonists in COPD [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating long-acting muscarinic antagonists in chronic obstructive pulmonary disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: University of Dundee | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 4 | Status: COMPLETED